Association between frailty index and all-cause mortality in hospitalized elderly patients with osteoporotic fractures: a retrospective cohort study

老年骨质疏松性骨折住院患者衰弱指数与全因死亡率之间的关联:一项回顾性队列研究

阅读:2

Abstract

BACKGROUND: Osteoporotic fractures (OPF) represent a significant health concern among the elderly population. Frailty, a prevalent condition in this demographic, can be evaluated via the Frailty Index (FI). This study investigated the association between FI and all-cause mortality (ACM) in aged individuals with osteoporosis (OP). METHODS: This retrospective cohort study included 19,332 patients who underwent surgical treatment for fractures at Kunshan First People's Hospital between January 1, 2017, and August 31, 2023. Among these, 4,782 patients aged ≥ 50 years were diagnosed with OPF. The FI was developed based on 30 health indicators, and it requires the availability of at least 75% of the variables for all patients. Moreover, ACM was monitored from the time of hospitalization until death or the end of the study period. Data on the correlation between FI and ACM were statistically evaluated, including the Cox proportional hazard regression model, interaction test, smooth curve fitting, K-M survival curve, threshold effect, subgroup, and sensitivity analyses. RESULTS: Among the 3,833 patients, the mean age was 68.77 years, with an average FI of 0.07. A substantial positive correlation was observed between FI and ACM (HR = 1.05, 95% CI: 1.03-1.07, p < 0.01). Importantly, a 0.033 increase in the FI score (equivalent to ~ 1 additional cumulative deficit) was related to a 17% higher risk of ACM (HR: 1.17, 95% CI: 1.10 to 1.24). Subgroup analyses further validated these findings across diverse demographic groups. CONCLUSION: This study establishes a significant correlation between the FI and ACM in elderly patients with OPF, underscoring the importance of frailty measurement in clinical management. These findings support the need for targeted interventions to improve outcomes in this high-risk population and emphasize the necessity of further research to develop effective screening and management strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。